CV Lattes
Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP) (Institutional affiliation for the last research proposal) Birthplace: Brazil
Pharmacist at Federal University of Espírito Santo (2014) and Master Degree in Biochemistry and Pharmacology at Federal University of Espírito Santo (2016). Currently, PhD student enrolled on double-degree in Pharmaceutical Sciences Post-Graduate Program at Universtiy of São Paulo (USP; Brazil) and Department of Clinical Medicina at Aarhus University (AU; Denmark), investigating the psychopharmacology area, focus on the neurobiology of depression and anxiety. (Source: Lattes Curriculum)
Depression is a debilitating psychiatric disorder. Antidepressants have limitations on their use, such as the delay of four to six weeks for onset of therapeutic action and inefficiency in 30-45% of patients.Among the substances that present a better therapeutic profile are cannabidiol (CBD), which showed a rapid and sustained antidepressant effect in animal models. The mechanisms respons…
Depression is a debilitating and disabling psychiatric disorder. Dysfunction on pre-frontal cortex (PFC) have been related to depression. Ketamine is an important drug that produces rapid and sustained antidepressant effects, which seems to involve activation of the BDNF-TrkB-mTOR pathway, with subsequent activation of MEK and PI3K, leading to increased synaptogenesis. We have recently sh…
| 1 / 1 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 2 / 2 | All Scholarships |
| Associated processes | |
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
SILOTE, GABRIELA P.; DE OLIVEIRA, SABRINA F. S.; RIBEIRO, DEIDIANE E.; MACHADO, MAYARA S.; ANDREATINI, ROBERTO; JOCA, SAMIA R. L.; BEIJAMINI, VANESSA. Ketamine effects on anxiety and fear-related behaviors: Current literature evidence and new findings. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, v. 100, JUN 8 2020. Web of Science Citations: 0. (17/26815-1, 18/12119-6)